TrialThe New England journal of medicine2015
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer.
Hossein Borghaei et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5,281 papers cite itlatest 60 shown
this paperpooled ittrialcites it